{"id":48625,"date":"2022-09-21T08:02:07","date_gmt":"2022-09-21T06:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/"},"modified":"2022-09-21T08:02:07","modified_gmt":"2022-09-21T06:02:07","slug":"onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/","title":{"rendered":"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022"},"content":{"rendered":"
\n

EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it will publish half-year 2022 financial and operating results on Tuesday, September 27, 2022. Management will host a webcast to discuss operational and financial highlights, as well as provide a business update on September 27, 2022, at 16:00 CEST\/10:00 EDT.\n<\/p>\n

\nTo join the webcast via Zoom, please use this link<\/a>.\n<\/p>\n

<\/a><\/p>\n

\nParticipants may also join by phone:\n<\/p>\n

\n+32 2 290 9360 (Belgium)
\n
+49 69 3807 9884 (Germany)
\n
+31 20 794 0854 (Netherlands)
\n
+41 22 591 01 56 (Switzerland)
\n
+44 203 481 5240 (United Kingdom)
\n
+1 346 248 7799 (US)
\n
International numbers available<\/a>\n<\/p>\n

\nWebinar ID: 840 0768 4745\n<\/p>\n

\nA recording of the webcast will be available on the Company\u2019s website<\/a> following the live event.\n<\/p>\n

\nTo learn more about ONWARD\u2019s ARC Therapy and the company\u2019s vision to restore movement, independence and health in people with spinal cord injury, please visit ONWD.com<\/a>.\n<\/p>\n

\nAbout ONWARD Medical<\/b>\n<\/p>\n

\nONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries. ONWARD\u2019s work builds on more than a decade of basic science and preclinical research conducted at the world\u2019s leading neuroscience laboratories. ONWARD\u2019s ARC Therapy, which can be delivered by implantable (ARC-IM) or external (ARC-EX) systems, is designed to deliver targeted, programmed spinal-cord stimulation to restore movement and other functions in people with spinal cord injury, ultimately improving their quality of life.\n<\/p>\n

\nONWARD has received three Breakthrough Device Designations from the U.S. FDA encompassing both ARC-IM <\/sup>and ARC-EX. ARC-EX is an external, non-invasive platform consisting of a wearable stimulator and wireless programmer. Positive top-line data were reported in September 2022 from the company\u2019s first pivotal study, called Up-LIFT, evaluating the ability of ARC-EX Therapy to improve upper extremity strength and function. The company is now preparing marketing approval submissions for the U.S. and Europe. ARC-IM consists of an implantable pulse generator and lead that is placed near the spinal cord. The company completed its first-in-human use of the ARC-IM neurostimulator in May 2022.\n<\/p>\n

\nONWARD is headquartered at the High Tech Campus in Eindhoven, the Netherlands. It has substantial operations in Lausanne, Switzerland, and a growing U.S. presence in Boston, Massachusetts, USA. For additional information about the company, please visit ONWD.com<\/a>. To access our 2022 Financial Calendar, please visit IR.ONWD.com<\/a>.\n<\/p>\n

\nDisclaimer<\/b>\n<\/p>\n

\nCertain statements, beliefs, and opinions in this press release are forward-looking, which reflect the Company or, as appropriate, the Company directors\u2019 current expectations and projections about future events. By their nature, forward-looking statements involve several risks, uncertainties, and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition, and technology, can cause actual events, performance, or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions, or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person\u2019s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor Company Enquiries:
\n
info@onwd.com<\/a><\/p>\n

For Media Enquiries:
\n
MC Services AG
\n
US: Laurie Doyle, P: +1 339 832 0752
\n
Europe: Dr. Johanna Kobler, Katja Arnold, Kaja Skorka P: +49 89 210 228 0
\n
media@onwd.com<\/a>\n<\/p>\n

\nFor Investor Enquiries:
\n
investors@onwd.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it will publish half-year 2022 financial and operating results on Tuesday, September 27, 2022. Management will host a webcast to discuss … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48625","6":"format-standard","7":"category-industry"},"yoast_head":"\nONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it will publish half-year 2022 financial and operating results on Tuesday, September 27, 2022. Management will host a webcast to discuss ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-21T06:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220920006122\/en\/1577889\/21\/Logo_Onward.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022\",\"datePublished\":\"2022-09-21T06:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/\"},\"wordCount\":697,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220920006122\\\/en\\\/1577889\\\/21\\\/Logo_Onward.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/\",\"name\":\"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220920006122\\\/en\\\/1577889\\\/21\\\/Logo_Onward.jpg\",\"datePublished\":\"2022-09-21T06:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220920006122\\\/en\\\/1577889\\\/21\\\/Logo_Onward.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220920006122\\\/en\\\/1577889\\\/21\\\/Logo_Onward.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/","og_locale":"en_US","og_type":"article","og_title":"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022 - Pharma Trend","og_description":"EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it will publish half-year 2022 financial and operating results on Tuesday, September 27, 2022. Management will host a webcast to discuss ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-21T06:02:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220920006122\/en\/1577889\/21\/Logo_Onward.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022","datePublished":"2022-09-21T06:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/"},"wordCount":697,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220920006122\/en\/1577889\/21\/Logo_Onward.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/","url":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/","name":"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220920006122\/en\/1577889\/21\/Logo_Onward.jpg","datePublished":"2022-09-21T06:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220920006122\/en\/1577889\/21\/Logo_Onward.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220920006122\/en\/1577889\/21\/Logo_Onward.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/onward-to-release-half-year-2022-financial-results-and-host-webcast-on-september-27-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48625"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48625\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}